Matured hiPSC-derived cardiomyocytes possess dematuration plasticity

Fang Meng , Maxwell Kwok , Yen Chin Hui , Ruofan Wei , Alejandro Hidalgo-Gonzalez , Anna Walentinsson , Henrik Andersson , Frederik Adam Bjerre , Qing-Dong Wang , Ditte C. Andersen , Ellen Ngar-Yun Poon , Daniela Später , David C. Zebrowski
{"title":"Matured hiPSC-derived cardiomyocytes possess dematuration plasticity","authors":"Fang Meng ,&nbsp;Maxwell Kwok ,&nbsp;Yen Chin Hui ,&nbsp;Ruofan Wei ,&nbsp;Alejandro Hidalgo-Gonzalez ,&nbsp;Anna Walentinsson ,&nbsp;Henrik Andersson ,&nbsp;Frederik Adam Bjerre ,&nbsp;Qing-Dong Wang ,&nbsp;Ditte C. Andersen ,&nbsp;Ellen Ngar-Yun Poon ,&nbsp;Daniela Später ,&nbsp;David C. Zebrowski","doi":"10.1016/j.jmccpl.2025.100295","DOIUrl":null,"url":null,"abstract":"<div><div>Human induced Pluripotent Stem Cell-derived cardiomyocytes (hiPSC-CMs) are increasingly used to identify potential factors capable of inducing endogenous cardiomyocyte proliferation to regenerate the injured heart. L-type calcium channel blockers have previously been identified as a class of factors capable of inducing matured hiPSC-CMs to proliferate. However, the mechanism by which L-type calcium channel blockers promote hiPSC-CM proliferation remains unclear. Here we provide evidence that matured hiPSC-CMs possess plasticity to undergo dematuration in response to certain pharmacological compounds. Consistent with primary cardiomyocyte maturation during perinatal development, we found that centrosome disassembly occurs in hiPSC-CMs during plate-based, temporal, maturation. A small molecule screen identified nitrendipine, an L-type calcium channel blocker, and 1-NA-PP1, a Src kinase inhibitor, as factors capable of inducing centrosome reassembly in a subpopulation of hiPSC-CMs. Furthermore, centrosome-positive hiPSC-CMs were more likely to exhibit cell cycle activity than centrosome-negative hiPSC-CMs. In contrast, neither nitrendipine or 1-NA-PP1 induced centrosome reassembly, or cell cycle activity, in neonatal rat ventricular myocytes (NRVMs). Differential bulk transcriptome analysis indicated that matured hiPSC-CMs, but not NRVMs, treated with nitrendipine or 1-NA-PP1 undergo dematuration. ScRNA transcriptome analysis supported that matured hiPSC-CMs treated with either nitrendipine or 1-NA-PP1 undergo dematuration. Collectively, our results indicate that matured hiPSC-CMs, but not primary NRVMs, possess plasticity to undergo dematuration in response to certain pharmacological compounds such as L-type calcium channel blockers and Src-kinase inhibitors. This study shows that once mature, hiPSC-CMs may not maintain their maturity under experimental conditions which may have implications for experimental systems where the state of hiPSC-CM maturation is relevant.</div></div>","PeriodicalId":73835,"journal":{"name":"Journal of molecular and cellular cardiology plus","volume":"12 ","pages":"Article 100295"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of molecular and cellular cardiology plus","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772976125000145","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Human induced Pluripotent Stem Cell-derived cardiomyocytes (hiPSC-CMs) are increasingly used to identify potential factors capable of inducing endogenous cardiomyocyte proliferation to regenerate the injured heart. L-type calcium channel blockers have previously been identified as a class of factors capable of inducing matured hiPSC-CMs to proliferate. However, the mechanism by which L-type calcium channel blockers promote hiPSC-CM proliferation remains unclear. Here we provide evidence that matured hiPSC-CMs possess plasticity to undergo dematuration in response to certain pharmacological compounds. Consistent with primary cardiomyocyte maturation during perinatal development, we found that centrosome disassembly occurs in hiPSC-CMs during plate-based, temporal, maturation. A small molecule screen identified nitrendipine, an L-type calcium channel blocker, and 1-NA-PP1, a Src kinase inhibitor, as factors capable of inducing centrosome reassembly in a subpopulation of hiPSC-CMs. Furthermore, centrosome-positive hiPSC-CMs were more likely to exhibit cell cycle activity than centrosome-negative hiPSC-CMs. In contrast, neither nitrendipine or 1-NA-PP1 induced centrosome reassembly, or cell cycle activity, in neonatal rat ventricular myocytes (NRVMs). Differential bulk transcriptome analysis indicated that matured hiPSC-CMs, but not NRVMs, treated with nitrendipine or 1-NA-PP1 undergo dematuration. ScRNA transcriptome analysis supported that matured hiPSC-CMs treated with either nitrendipine or 1-NA-PP1 undergo dematuration. Collectively, our results indicate that matured hiPSC-CMs, but not primary NRVMs, possess plasticity to undergo dematuration in response to certain pharmacological compounds such as L-type calcium channel blockers and Src-kinase inhibitors. This study shows that once mature, hiPSC-CMs may not maintain their maturity under experimental conditions which may have implications for experimental systems where the state of hiPSC-CM maturation is relevant.

Abstract Image

成熟的hipsc衍生心肌细胞具有去成熟可塑性
人诱导多能干细胞衍生的心肌细胞(hiPSC-CMs)越来越多地用于鉴定能够诱导内源性心肌细胞增殖以再生损伤心脏的潜在因素。l型钙通道阻滞剂以前被确定为一类能够诱导成熟的hiPSC-CMs增殖的因子。然而,l型钙通道阻滞剂促进hiPSC-CM增殖的机制尚不清楚。在这里,我们提供的证据表明,成熟的hiPSC-CMs具有可塑性,可以在某些药理化合物的作用下进行去成熟。与围产期初级心肌细胞成熟相一致,我们发现hiPSC-CMs在基于板的、时间的成熟过程中发生中心体解体。通过小分子筛选发现,nitrendipine(一种l型钙通道阻滞剂)和1-NA-PP1(一种Src激酶抑制剂)是hiPSC-CMs亚群中能够诱导中心体重组的因子。此外,中心体阳性的hiPSC-CMs比中心体阴性的hiPSC-CMs更有可能表现出细胞周期活性。相比之下,尼群地平或1-NA-PP1均不能诱导新生大鼠心室肌细胞(nrvm)的中心体重组或细胞周期活性。差异体转录组分析表明,成熟的hiPSC-CMs,而非nrvm,经尼群地平或1-NA-PP1处理后,会经历去成熟过程。ScRNA转录组分析支持用尼群地平或1-NA-PP1处理的成熟hiPSC-CMs都经历了去成熟过程。总的来说,我们的研究结果表明,成熟的hiPSC-CMs,而不是初级nrvm,在某些药理化合物(如l型钙通道阻滞剂和src激酶抑制剂)的作用下,具有可塑性,可以进行去成熟。本研究表明,一旦成熟,hiPSC-CMs在实验条件下可能无法保持其成熟度,这可能对与hiPSC-CM成熟状态相关的实验系统产生影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of molecular and cellular cardiology plus
Journal of molecular and cellular cardiology plus Cardiology and Cardiovascular Medicine
自引率
0.00%
发文量
0
审稿时长
31 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信